참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | Methanesulfonyl chloride | HCID 31297 | — |
| 반응물 | 1-[4-(2,2,2-Trifluoroethoxy)phenyl]piperazine | HCID 43510344 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 1-(Methylsulfonyl)-4-[4-(2,2,2-trifluoroethoxy)phenyl]piperazine | HCID 21068624 | 19.5% |
반응 단계
1-[4-(2,2,2-trifluoroethoxy)phenyl]piperazine (13.48 g, 50 mmol) was dissolved in DCM (500 mL) and cooled to 0° C. Triethylamine (29 mL, 0.2 mol) was added, followed by the dropwise addition of methanesulfonyl chloride (4.2 mL, 55 mmol). The reaction was then allowed to warm to room temperature and stir overnight, before being quenched by the addition of water. The layers were separated, and the organic phase dried (MgSO4), filtered and concentrated. The residue was recrystallised from hot ethanol to give pure 1-(methylsulfonyl)-4-[4-(2,2,2-trifluoroethoxy)phenyl]piperazine (3.3 g, 18%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07485644B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_02 |
|---|
| ORD ID | ord-0c7223e91e814e678a6c46b4b906b5a2 |
|---|
| 출처 메모 | uspto-grants-2009_02 |
|---|